General Information of the Compound
| Compound ID |
CP0850729
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(alphaS)-alpha-[3-[(aminoiminomethyl)amino]propyl]-5-[[3-methyl-4-(3-methylphenyl)-1-piperazinyl]carbonyl]-2-(3-phenoxyphenyl)-1H-benzimidazole-1-acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H42N8O3
|
||||||||||||||||||
| Molecular Weight |
658.807
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(N2CCN(C(=O)c3ccc4c(c3)nc(-c3cccc(Oc5ccccc5)c3)n4[C@@H](CCCNC(=N)N)C(N)=O)CC2C)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H42N8O3/c1-25-9-6-11-29(21-25)45-20-19-44(24-26(45)2)37(48)28-16-17-33-32(23-28)43-36(46(33)34(35(39)47)15-8-18-42-38(40)41)27-10-7-14-31(22-27)49-30-12-4-3-5-13-30/h3-7,9-14,16-17,21-23,26,34H,8,15,18-20,24H2,1-2H3,(H2,39,47)(H4,40,41,42)/t26?,34-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UQVCYLRXNFFGEG-BFZOCEIISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00634, Mas-related G protein-coupled receptor X1
Protein ID: PT04369, Mas-related G-protein coupled receptor member X1